Completed from United Kingdom
The Executive Certificate in Pharmaceutical Regulatory Affairs (Intermediate) exceeded my expectations. The curriculum was tightly aligned with my goal of mastering EU regulatory submissions, and the modules on the Centralised Procedure and Variations gave me the confidence to draft a complete marketing authorisation dossier for my employer. The case studies on post‑marketing surveillance were especially useful, allowing me to apply risk‑management tools directly to a real‑world product. Course materials were up‑to‑date, with clear templates and regulatory excerpts that saved me hours of research. Overall, the learning experience was highly professional and has already translated into a promotion at my company.
I took this course because I wanted a solid bridge between my biotech background and the FDA world. The instructors broke down the IND filing process into bite‑size steps, and the hands‑on assignment where we prepared a mock submission was a game‑changer. I also liked the practical tips on navigating the 510(k) pathway – something I could use right away at my startup. The reading list was spot‑on, and the videos were easy to follow. It was a relaxed, yet informative vibe, and I left feeling ready to take on regulatory challenges in the US.
Wow! This course was exactly what I needed to boost my career in pharma regulatory affairs. The modules on global harmonisation, especially the ICH guidelines, helped me understand how to align Indian submissions with international expectations. I especially loved the live workshop where we simulated a product recall and practiced drafting a Corrective Action Plan – I can now confidently lead such initiatives at my organization. The resources were current, with interactive quizzes that reinforced each topic. My enthusiasm grew with every session, and I’m already recommending it to my colleagues.
The Intermediate Executive Certificate offered a thorough and detailed exploration of regulatory affairs that matched my learning objectives. The detailed breakdown of the South African Health Products Regulatory Authority (SAHPRA) application process, combined with comparative analysis of the EU and US frameworks, gave me a solid foundation for cross‑border projects. Practical exercises, such as preparing a product labeling dossier and conducting a gap analysis for a legacy drug, were directly applicable to my daily work. Course materials were well‑structured, with downloadable checklists that I now use regularly. The overall experience was comprehensive and highly relevant to the African market.
